Mesa Laboratories, Inc.

MLAB
$124.76 (+ $5.61 + 4.71%)
Last updated: 2026-08-22 03:48 UTC
MLAB Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorTechnology
IndustryScientific & Technical Instruments
ISINUS59064R1095
CUSIP59064R109
Market Price124.76
Dividend Yield 0.51%
Dividend Growth
1Y +50.00%
3Y +5.27%
5Y +1.92%
10Y +2.98%
Annual Dividend 0.96
Latest Payout ($)0.16
Latest Payout Date2026-06-15
Dividend FrequencyQuarterly
P/E Ratio144.93
EPS-0.31
Market Cap$445.5M
Book Value32.38
Price to Book2.491
Beta0.9
52w High124.89
52w Low58.83
Next Earnings DateN/A

Mesa Laboratories, Inc. trades under ticker MLAB on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Technology exposure. Identifiers: ISIN US59064R1095, CUSIP 59064R109. Also searched as Mesa Laboratories.

Related researchMLAB stock priceMLAB share priceMLAB dividend historyMLAB dividend yieldMesa Laboratories dividend historyMesa Laboratories dividend yield59064R109Mesa Laboratories stockMesa Laboratories share price
About the Company
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Price History